Antimicrobial Pulpotomy of Primary Molars

Phase 4

Completed

• Conditions: Inflammation; Necrosis

• Registration Number: NCT01010451
• Lead Sponsor: Universidade Federal de Goias

Brief Summary

There is a lack of evidence of the long-term successful outcomes of antimicrobial endodontic treatment for primary teeth. This study intended to evaluate (by survival analysis) the effectiveness of an antimicrobial pulpotomy (chloramphenicol, tetracycline, zinc oxide/eugenol) in primary molars compared to calcium hydroxide pulpectomy, testing the hypothesis that antimicrobial pulpotomy could be an alternative pulp therapy for primary teeth with pulp inflammation or necrosis.

Detailed Description

Not available

Study Timeline

• Study Start: 2000-08
• Study Completion: 2006-08
• Status Verified: 2009-11
• Study First Submitted: 2009-11-06
• Study First Submitted QC: 2009-11-09
• Last Update Submitted: 2009-11-09
• Study First Posted: 2009-11-10
• Last Update Posted: 2009-11-10

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

• Healthy children (ASA PS 1)
• Children presenting one or more primary molar with pulp inflammation or necrosis due to carious lesion and indicated for endodontic therapy

Exclusion Criteria

• Lost to follow-up

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Trial Locations

Locations (1)

Dental School; 🇧🇷 Goiânia, Goiás, Brazil